Báo cáo thường niên năm 2023 của 4D Molecular Therapeutics, Inc.

4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Their vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to … More invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Their product design, development and manufacturing engine empowers them to efficiently create their valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. They have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.